Products

Kulma

Stop digging through GA4. Get what actually matters this week.

kulma.co Data & Analytics / Website Analytics

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$29/mo
Higher than 78% of peersNiche median $10/mo
Creators
Kulma Co
No social account linked
Launched
6mo ago
2026-05-10 · Est.

Traffic

Last 12 months
Monthly visitsData through Sep 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Skip the GA4 dashboard. Get the weekly brief instead.

    May 10 · 6mo agoLaunch page

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search30%
  • Referrals10%
  • Social6%
  • Other14%

Countries

  • United States100%

Search

Domain authority —Domain registered 2026-03-21

KeywordMonthly volume
why is the revenue unassigned in ga4330

Traffic data: Vaneform

Pricing

Basic
$29/mo
1 GA4 property
Basic Plus
$49/mo
a single property
Standard
$79/mo
Up to 3 GA4 properties
Pro
$199/mo
Up to 10 GA4 properties

Trial: 14-day free trial · 4 paid tiers ($29–$199) · Observed 2026-11-02 · Source page

Entry price $29/mo, Higher than 78% of peers; “Website Analytics” median is $10/mo.View pricing benchmark

Pages & changes

Tracked since 2026-05-10

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Kulma cost?
Basic: $29/mo; Basic Plus: $49/mo; Standard: $79/mo; Pro: $199/mo. Observed 2026-11-02. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Kulma get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate does not measure paying customers or revenue.Source

Related products in this category

Data & Analytics / Website Analytics

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.